Page last updated: 2024-09-05

organophosphonates and Hypertension

organophosphonates has been researched along with Hypertension in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.55)18.7374
1990's4 (18.18)18.2507
2000's10 (45.45)29.6817
2010's7 (31.82)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aguilar, A; De La Torre, J; Del Arco, A; García-Alegría, J; Olalla, J; Pombo, M; Prada, JL; Ruiz-Mateas, F; Urdiales, D1
Aiestarán, A; Bonet, J; Bonjoch, A; Clotet, B; Echeverría, P; Juega, J; Negredo, E; Pérez, V; Pérez-Alvarez, N; Puig, J; Romero, R1
Canale, D; Costa, Nde S; Gois, PH; Luchi, WM; Seguro, AC; Shimizu, MH; Veras, MM; Volpini, RA1
Huang, J; Huang, S; Lassman, C; Lum, EL1
Bonnet, F; Dabis, F; Déti, EK; Dupon, M; Lawson-Ayayi, S; Malvy, D; Morlat, P; Neau, D; Pellegrin, JL; Tchamgoué, S; Thiébaut, R1
Brooks, JT; Bush, T; Conley, L; Hammer, J; Henry, K; Kojic, EM; Mondy, K; Overton, ET; Patel, P; Rhame, F1
Drevenšek, G; Ljuca, F; Zerem, E1
Ayach, B; Battistini, B; Blouin, A; Jeng, AY; Molez, S1
Emoto, N1
Perlini, S1
Amiri, F; Gannon, P; Pu, Q; Schiffrin, EL1
Battistini, B; Blouin, A; Daull, P; Jeng, AY; Nantel, F; Sirois, P1
Akhtar, S; Alshawaf, EH; Benter, IF; Canatan, H; Cojocel, C; Francis, I; Juggi, JS; Khan, I; Yousif, MH1
Arsenault, D; Battistini, B; Beaudoin, M; Belleville, K; Benrezzak, O; Blouin, A; Cayer, J; Daull, P; Jeng, AY; Nantel, F; Pheng, LH; Sirois, P1
Beniowski, M; Gargalianos, P; Gatell, J; Kirk, O; Lundgren, JD; Mocroft, A; Reiss, P; Staszewski, S; Viard, JP; Zilmer, K1
Atta, MG; Fine, DM; Lucas, GM; Perazella, MA1
Beil, ME; Coté, DT; de Lombaert, S; Erion, MD; Gerlock, TE; Ghai, RD; Hopkins, MF; Peppard, JV; Trapani, AJ; Webb, RL1
De Lombaert, S; Erion, MD; Ghai, RD; Lappe, RW; Peppard, JV; Trapani, AJ; Worcel, M1
Chappell, MC; Ferrario, CM; Iyer, SN1
deWit, D; Emoto, N; Télémaque, S; Yanagisawa, M1
Pu, Q; Schiffrin, EL; Touyz, RM1
Cliff, WJ; Fleisher, JH; Harris, LW; Vick, JA1

Reviews

2 review(s) available for organophosphonates and Hypertension

ArticleYear
[Physiological and pathophysiological roles of the endothelin converting enzymes].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Animals; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Drug Design; Endothelin-Converting Enzymes; Glycopeptides; Heart Failure; Humans; Hypertension; Metalloendopeptidases; Mice; Mice, Knockout; Myocardial Infarction; Organophosphonates; Phenylalanine; Tetracyclines; Tetrazoles

2004
Kidney biopsy in HIV: beyond HIV-associated nephropathy.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 51, Issue:3

    Topics: Acute Disease; Adenine; AIDS-Associated Nephropathy; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biopsy; Comorbidity; Diabetic Nephropathies; Diagnosis, Differential; Female; HIV Infections; Humans; Hypertension; Immune Complex Diseases; Kidney; Kidney Diseases; Kidney Glomerulus; Middle Aged; Nephritis, Interstitial; Organophosphonates; Risk Assessment; Risk Factors; Tenofovir

2008

Other Studies

20 other study(ies) available for organophosphonates and Hypertension

ArticleYear
Left ventricular hypertrophy detected by echocardiography in HIV-infected patients.
    European journal of internal medicine, 2013, Volume: 24, Issue:6

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Carbamates; Comorbidity; Cross-Sectional Studies; Cyclopropanes; Diabetes Mellitus; Drug Combinations; Dyslipidemias; Echocardiography; Female; Furans; HIV Infections; Humans; Hypertension; Hypertrophy, Left Ventricular; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Organophosphates; Organophosphonates; Risk Factors; Ritonavir; Smoking; Spain; Sulfonamides; Tenofovir; Zidovudine

2013
High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.
    AIDS patient care and STDs, 2014, Volume: 28, Issue:10

    Topics: Adenine; Adult; Age Factors; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Diabetes Mellitus; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Prevalence; Prospective Studies; Risk Factors; Socioeconomic Factors; Spain; Surveys and Questionnaires; Tenofovir; Viral Load

2014
Tenofovir during pregnancy in rats: a novel pathway for programmed hypertension in the offspring.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4

    Topics: Adenine; Animals; Antiviral Agents; Biological Transport, Active; Female; Hypertension; Models, Animal; Organophosphonates; Pregnancy; Rats, Wistar; Renin-Angiotensin System; Sodium; Tenofovir

2015
Quiz Page January 2015: acute kidney injury in a patient with well-controlled HIV infection.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 65, Issue:1

    Topics: Acute Kidney Injury; Adenine; Aged, 80 and over; Anti-HIV Agents; Biopsy; CD4 Lymphocyte Count; Diagnosis, Differential; Diarrhea; HIV Infections; Humans; Hypertension; Immunologic Tests; Kidney; Kidney Function Tests; Male; Monitoring, Physiologic; Organophosphonates; Ritonavir; Tenofovir; Treatment Outcome; Viral Load; Withholding Treatment

2015
Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France.
    HIV medicine, 2010, Volume: 11, Issue:5

    Topics: Adenine; Adult; Anti-HIV Agents; Body Mass Index; CD4 Lymphocyte Count; Creatinine; Epidemiologic Methods; Female; France; HIV Infections; Humans; Hypertension; Indinavir; Kidney; Kidney Function Tests; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Tenofovir

2010
Cystatin C and baseline renal function among HIV-infected persons in the SUN Study.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:2

    Topics: Adenine; Adult; Anti-HIV Agents; Body Mass Index; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Cystatin C; Female; Glomerular Filtration Rate; Hepatitis C; HIV Seropositivity; Humans; Hypertension; Male; Organophosphonates; Prospective Studies; Renal Insufficiency; Ritonavir; Tenofovir

2012
Contribution of Ras farnesyl transferase, MAP kinase and cytochrome P-450 metabolites to endothelin-1 induced hypertension.
    Bosnian journal of basic medical sciences, 2011, Volume: 11, Issue:2

    Topics: Alkyl and Aryl Transferases; Animals; Arachidonic Acid; Blood Pressure; Cytochrome P-450 Enzyme System; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Fatty Acids, Unsaturated; Flavonoids; Hypertension; Infusions, Intravenous; Male; MAP Kinase Signaling System; Organophosphonates; Rats; Rats, Sprague-Dawley; Signal Transduction

2011
Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
    Clinical science (London, England : 1979), 2002, Volume: 103 Suppl 48

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Blood Pressure; Drug Therapy, Combination; Endothelin-1; Endothelin-Converting Enzymes; Hypertension; Male; Metalloendopeptidases; Organophosphonates; Rats; Rats, Inbred SHR; Rats, Inbred WKY

2002
The potential advantage of omapatrilat: dual anti-fibrotic and anti-inflammatory effects in one single molecule.
    Journal of hypertension, 2005, Volume: 23, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cell Adhesion Molecules; Desoxycorticosterone; Drug Therapy, Combination; Fibrosis; Heart Diseases; Hypertension; Inflammation; Kidney Diseases; Metalloendopeptidases; Neprilysin; Organophosphonates; Pyridines; Rats; Thiazepines

2005
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats.
    Journal of hypertension, 2005, Volume: 23, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Cell Adhesion Molecules; Collagen; Desoxycorticosterone; Drug Therapy, Combination; Enalapril; Fibrosis; Heart Diseases; Hypertension; Inflammation; Kidney Diseases; Metalloendopeptidases; Neprilysin; NF-kappa B; Organophosphonates; Pyridines; Rats; Rats, Sprague-Dawley; Thiazepines

2005
Triple vasopeptidase inhibition of angiotensin-converting enzyme/neutral endopeptidase/endothelin-converting enzyme activities on the hemodynamic profile of chronically instrumented unrestrained conscious spontaneously hypertensive rats.
    Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aspartic Acid Endopeptidases; Benzazepines; Benzofurans; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin-Converting Enzymes; Heart Rate; Hypertension; Infusions, Intra-Arterial; Male; Metalloendopeptidases; Neprilysin; Organophosphonates; Phenylalanine; Rats; Rats, Inbred SHR; Time Factors

2004
Signal transduction involving Ras-GTPase contributes to development of hypertension and end-organ damage in spontaneously hypertensive rats-treated with L-NAME.
    Pharmacological research, 2005, Volume: 52, Issue:5

    Topics: Animals; Blood Pressure; Collagen Type III; Hypertension; Isoproterenol; Kidney; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Organophosphonates; ras Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Sodium-Hydrogen Exchangers; Ventricular Function, Left

2005
Triple vasopeptidase inhibition normalizes blood pressure in conscious, unrestrained, and spontaneously hypertensive rats.
    American journal of hypertension, 2005, Volume: 18, Issue:12 Pt 1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Benzazepines; Benzofurans; Blood Pressure; Dose-Response Relationship, Drug; Endothelin-1; Endothelin-Converting Enzymes; Hypertension; Indoles; Male; Metalloendopeptidases; Neprilysin; Nitric Oxide; Organophosphonates; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species

2005
Chronic renal failure among HIV-1-infected patients.
    AIDS (London, England), 2007, May-31, Volume: 21, Issue:9

    Topics: Adenine; Adult; Aged; Anti-Retroviral Agents; CD4 Lymphocyte Count; Creatinine; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypertension; Indinavir; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; Tenofovir

2007
Pharmacologic profile of CGS 24128, a potent, long-acting inhibitor of neutral endopeptidase 24.11.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:3

    Topics: Amino Acid Sequence; Animals; Atrial Natriuretic Factor; beta-Alanine; Blood Pressure; Desoxycorticosterone; Diuresis; Heart Rate; Hypertension; Kidney; Male; Molecular Sequence Data; Natriuresis; Neprilysin; Organophosphonates; Peptide Fragments; Rats; Rats, Sprague-Dawley; Thiorphan

1994
The pharmacology of CGS 25462: a potent, orally bioavailable, long-acting inhibitor of neutral endopeptidase 24.11.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1993, Volume: 11, Issue:5

    Topics: Administration, Oral; Amino Acid Sequence; Animals; Atrial Natriuretic Factor; Biological Availability; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Molecular Sequence Data; Neprilysin; Oligopeptides; Organophosphonates; Prodrugs; Rats; Substrate Specificity

1993
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
    Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Pt 2

    Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System

1998
In vivo role of endothelin-converting enzyme-1 as examined by adenovirus-mediated overexpression in rats.
    Journal of cardiovascular pharmacology, 1998, Volume: 31 Suppl 1

    Topics: Adenoviridae Infections; Animals; Aspartic Acid Endopeptidases; Azepines; Blood Pressure; Cattle; DNA, Complementary; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Endothelins; Humans; Hypertension; Indoles; Male; Metalloendopeptidases; Organophosphonates; Protease Inhibitors; Protein Precursors; Rats; Rats, Wistar; Receptor, Endothelin A; Tetrazoles

1998
Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
    Journal of hypertension, 2002, Volume: 20, Issue:5

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Collagen; Desoxycorticosterone; Drug Therapy, Combination; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Male; Mesenteric Arteries; Myocardium; Neprilysin; Organ Size; Organophosphonates; Pyridines; Rats; Rats, Sprague-Dawley; Sodium Chloride; Systole; Thiazepines; Vascular Resistance

2002
Effects of 2-pyridinium aldoxine methochloride and atropine in relation to elevation of blood pH in soman-poisoned dogs.
    Biochemical pharmacology, 1969, Volume: 18, Issue:2

    Topics: Acetylcholinesterase; Acid-Base Equilibrium; Animals; Atropine; Blood Pressure; Cholinesterase Inhibitors; Dogs; Electrocardiography; Erythrocytes; Female; Heart Rate; Hydrogen-Ion Concentration; Hypertension; Injections, Intravenous; Male; Organophosphonates; Phenoxybenzamine; Pralidoxime Compounds; Respiration; Stimulation, Chemical; Time Factors

1969